Muhammad Absar; Nawaf Alanazi; Abdulaziz Siyal; Masood Shammas; Amer Mahmood; Sulman Basit; Sarah AlMukhaylid; Zafar Iqbal. CLINICAL VALIDATION OF ANKRD36 MUTATIONS AS A NOVEL BIOMARKER FOR MONITORING EARLY PROGRESSION AND TIMELY CLINICAL INTERVENTIONS IN BLAST CRISIS CML. J Popl Ther Clin Pharmacol 2022, 29 (02), 311-320. https://doi.org/10.53555/jptcp.v29i02.4161.